Upstream Bio Inc (UPB)

Currency in USD
2.065
-0.015(-0.72%)
Real-time Data·
UPB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0152.190
52 wk Range
2.00533.680
Key Statistics
Prev. Close
2.08
Open
2.09
Day's Range
2.015-2.19
52 wk Range
2.005-33.68
Volume
557.66K
Average Volume (3m)
982.76K
1-Year Change
-91.7201%
Book Value / Share
4.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
UPB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.400
Upside
+936.32%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Upstream Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 21.400
(+936.32% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy18.00+765.38%36.00MaintainNov 11, 2026
JPMorgan
Hold9.00+332.69%8.00MaintainAug 14, 2026
Truist Securities
Buy25.00+1,101.92%43.00MaintainAug 12, 2026
JPMorgan
Hold8.00+284.62%35.00DowngradeJun 12, 2026
H.C. Wainwright
Buy36.00+1,630.77%-New CoverageJun 03, 2026

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0.75 / -1.12
Revenue / Forecast
395K / --
EPS Revisions
Last 90 days

UPB Income Statement

Compare UPB to Peers and Sector

Metrics to compare
UPB
Peers
Sector
Relationship
P/E Ratio
−0.7x−1.7x−0.2x
PEG Ratio
0.05−0.150.00
Price/Book
0.5x2.3x2.6x
Price / LTM Sales
38.6x15.5x2.7x
Upside (Analyst Target)
-106.6%69.6%
Fair Value Upside
Unlock7.5%11.7%Unlock

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
20.39M37.20%42.41M
Other Institutional Investors
31.32M57.14%65.14M
Public Companies & Retail Investors
3.11M5.67%6.46M
Total
54.81M100.00%114.01M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
OrbiMed Advisors LLC10.39%5,693,58911,843
FMR LLC6.92%3,793,9307,891

People Also Watch

14.41
MLYS
+4.57%
7.800
TKNO
-1.02%
4.660
MNTN
+1.08%
3.330
BRSP
-2.63%
3.205
SPRY
-13.14%

FAQ

What Is the Upstream Bio (UPB) Stock Price Today?

The Upstream Bio stock price today is 2.065 USD.

What Stock Exchange Does Upstream Bio Trade On?

Upstream Bio is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Upstream Bio?

The stock symbol for Upstream Bio is "UPB."

What Is the Upstream Bio Market Cap?

As of today, Upstream Bio market cap is 114.010M USD.

What Is Upstream Bio's Earnings Per Share (TTM)?

The Upstream Bio EPS (TTM) is -3.01.

From a Technical Analysis Perspective, Is UPB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Upstream Bio Stock Split?

Upstream Bio has split 0 times.

How Many Employees Does Upstream Bio Have?

Upstream Bio has 75 employees.

What is the current trading status of Upstream Bio (UPB)?

As of Nov 19, 2026, Upstream Bio (UPB) is trading at a price of 2.065 USD, with a previous close of 2.080 USD. The stock has fluctuated within a day range of 2.015 USD to 2.190 USD, while its 52-week range spans from 2.005 USD to 33.680 USD.

What Is Upstream Bio (UPB) Price Target According to Analysts?

The average 12-month price target for Upstream Bio is 21.400 USD, with a high estimate of 40 USD and a low estimate of 9 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +936.32% Upside potential.

What Is the UPB Premarket Price?

UPB's last pre-market stock price is 2.070 USD. The pre-market share volume is 960.000, and the stock has decreased by -0.010, or -0.480%.

What Is the UPB After Hours Price?

UPB's last after hours stock price is 2.020 USD, the stock has decreased by -0.060, or -2.880%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.